Deferoxamine mesylate
- Product NDC
- 47781-624
- 11-digit product format
- 477810624
- Labeler code
- 47781
- Product ID
- 47781-624_8bb4e851-6f27-a582-cc49-546aad51df01
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferoxamine mesylate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Alvogen Inc.
- Application
- ANDA207384
- Marketing category
- ANDA
- Marketing start
- 2018-03-24
- Marketing end
- 0000-00-00
- Substance
- DEFEROXAMINE MESYLATE
- Active strength
- 2 g/1
- Pharmacologic classes
- Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-624-07 | 47781062407 | 1 VIAL in 1 CARTON (47781-624-07) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2018-04-23 | 0000-00-00 | No | No | Current |